Safety and Efficacy of ABT-494 (Upadacitinib), an Oral Jak1 Inhibitor, as Induction Therapy in Patients with Crohn's Disease: Results from Celest

Details 詳細情報について

• CRID

  1360011146569831424

• DOI

  10.1016/s0016-5085(17)34357-3

• ISSN

  00165085

• Web Site

  https://api.elsevier.com/content/article/PII:S0016508517343573?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0016508517343573?httpAccept=text/plain

• Data Source

  • Crossref